Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DFB64U
|
|||
| Drug Name |
SB-728mR-HSPC
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24; ICD-9: 42] | Phase 1 | [1] | |
| Company |
Sangamo BioSciences Brisbane, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02500849) A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nuclease (ZFN) CCR5 Modified CD34+ Hematopoietic Stem/Progenitor Cells (SB-728mR-HSPC) in HIV-1 (R5) Infected Patients. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.